Syros Pharmaceuticals (SYRS) Stock Chart & Stock Price History → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free SYRS Stock Alerts $5.06 +0.09 (+1.81%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Syros Pharmaceuticals Stock Price Performance5 Day Performance+1.20%1 Month Performance-6.12%3 Month Performance-26.13%6 Month Performance+88.10%Year-To-Date Performance-35.04%1 Year Performance+46.24% Receive SYRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyWhat’s Really Next for America…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. SYRS Stock Chart for Monday, May, 13, 2024 SYRS Chart by TradingView Syros Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$4.97$5.06+1.81%$5.16$4.9491,740 shs$135.25 million05/10/2024$5.01$4.97-0.80%$5.10$4.93139,469 shs$132.84 million05/09/2024$5.00$5.01+0.20%$5.30$5.0088,047 shs$133.91 million05/08/2024$5.15$5.00-2.91%$5.15$4.9075,114 shs$133.65 million05/07/2024$5.08$5.15+1.38%$5.32$5.06105,550 shs$137.66 million05/06/2024$5.13$5.08-0.97%$5.21$5.0737,546 shs$135.79 million Get the Latest News and Ratings for SYRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Syros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$5.20$5.13-1.35%$5.34$5.0595,319 shs$137.13 million05/02/2024$5.44$5.20-4.41%$5.64$5.19301,209 shs$139.00 million05/01/2024$5.40$5.44+0.74%$5.65$5.28199,560 shs$145.41 million04/30/2024$5.38$5.40+0.37%$5.43$5.2394,729 shs$144.34 million04/29/2024$5.04$5.38+6.75%$5.46$5.05113,590 shs$143.80 million04/26/2024$5.10$5.04-1.18%$5.12$4.9944,534 shs$134.72 million04/25/2024$5.07$5.10+0.59%$5.15$4.92128,568 shs$136.32 million04/24/2024$5.14$5.07-1.36%$5.20$5.0089,634 shs$135.52 million04/23/2024$4.99$5.14+3.01%$5.32$4.98172,666 shs$137.39 million04/22/2024$4.54$4.99+9.91%$5.03$4.57151,952 shs$133.38 million04/19/2024$4.72$4.54-3.81%$4.71$4.41262,896 shs$121.35 million04/18/2024$5.11$4.72-7.63%$5.06$4.72119,221 shs$126.17 million04/17/2024$5.56$5.11-8.09%$5.67$5.09125,722 shs$136.59 million04/16/2024$5.35$5.56+3.93%$5.76$5.18287,306 shs$147.06 million04/15/2024$5.39$5.35-0.74%$5.63$5.24148,071 shs$141.53 million04/12/2024$5.92$5.39-8.95%$5.95$5.33210,645 shs$142.57 million04/11/2024$5.53$5.92+7.05%$5.94$5.48258,089 shs$156.61 million04/10/2024$5.50$5.53+0.55%$5.62$5.21238,188 shs$146.29 million04/09/2024$4.50$5.50+22.22%$5.84$4.70991,107 shs$145.48 million04/08/2024$4.67$4.50-3.64%$4.70$4.50155,108 shs$119.03 million04/05/2024$4.82$4.67-3.11%$4.85$4.66129,574 shs$123.52 million04/04/2024$4.98$4.82-3.21%$5.17$4.73296,102 shs$127.49 million04/03/2024$4.64$4.98+7.44%$5.03$4.63430,399 shs$131.72 million04/02/2024$5.04$4.64-8.04%$5.02$4.55404,517 shs$122.60 million04/01/2024$5.35$5.04-5.79%$5.35$4.70355,438 shs$133.31 million03/29/2024$5.35$5.35$5.90$5.15318,254 shs$112.72 million03/28/2024$5.84$5.35-8.39%$5.90$5.15318,061 shs$112.72 million03/27/2024$6.25$5.84-6.56%$6.18$5.44431,796 shs$123.05 million03/26/2024$6.40$6.25-2.34%$6.47$6.22108,945 shs$131.69 million03/25/2024$6.27$6.40+2.07%$6.49$6.25156,006 shs$132.09 million03/22/2024$6.34$6.27-1.10%$6.34$6.2161,940 shs$132.11 million03/21/2024$6.33$6.34+0.16%$6.41$6.15107,069 shs$133.58 million03/20/2024$6.23$6.33+1.61%$6.38$5.9991,073 shs$133.37 million03/19/2024$6.10$6.23+2.13%$6.37$6.00128,839 shs$131.27 millionWhat’s Really Next for America… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now.03/18/2024$6.01$6.10+1.50%$6.23$5.99149,957 shs$128.53 million03/15/2024$6.03$6.01-0.33%$6.20$5.98222,457 shs$126.63 million03/14/2024$6.47$6.03-6.80%$6.49$5.85209,036 shs$127.05 million03/13/2024$6.46$6.47+0.15%$6.68$6.4173,821 shs$136.32 million03/12/2024$6.56$6.46-1.52%$6.59$6.4388,928 shs$136.11 million03/11/2024$6.77$6.56-3.10%$6.85$6.51101,899 shs$138.20 million03/08/2024$6.93$6.77-2.31%$7.27$6.75133,001 shs$142.64 million03/07/2024$7.13$6.93-2.81%$7.18$6.36346,090 shs$146.02 million03/06/2024$7.15$7.13-0.28%$7.25$7.09127,228 shs$150.23 million03/05/2024$7.60$7.15-5.92%$7.60$7.04279,967 shs$150.65 million03/04/2024$7.75$7.60-1.94%$7.90$7.41219,733 shs$160.13 million03/01/2024$7.26$7.75+6.75%$7.90$7.31415,371 shs$163.29 million02/29/2024$7.19$7.26+0.97%$7.51$7.11267,258 shs$152.97 million02/28/2024$7.34$7.19-2.04%$7.49$7.10295,710 shs$151.49 million02/27/2024$7.49$7.34-2.00%$7.96$7.04345,869 shs$154.65 million02/26/2024$7.26$7.49+3.17%$7.64$7.22153,201 shs$157.79 million02/23/2024$7.09$7.26+2.40%$7.66$6.96239,929 shs$152.97 million02/22/2024$7.04$7.09+0.71%$7.17$6.8275,674 shs$149.39 million02/21/2024$7.45$7.04-5.50%$7.62$6.82140,173 shs$148.33 million02/20/2024$7.18$7.45+3.76%$7.69$7.18169,525 shs$156.97 million02/19/2024$7.18$7.18$7.41$6.95170,900 shs$151.28 million02/16/2024$7.08$7.18+1.41%$7.41$6.95170,884 shs$151.28 million02/15/2024$7.12$7.08-0.56%$7.20$6.98121,914 shs$149.18 million02/14/2024$6.85$7.12+3.94%$7.17$6.81147,330 shs$150.02 million02/13/2024$7.03$6.85-2.56%$6.94$6.63198,314 shs$144.33 million02/12/2024$7.07$7.03-0.57%$7.32$6.92105,923 shs$148.12 million Related Companies: SGMT Stock Price Chart PDSB Stock Price Chart DMAC Stock Price Chart FGEN Stock Price Chart RPTX Stock Price Chart AMLX Stock Price Chart ACET Stock Price Chart NVCT Stock Price Chart RGLS Stock Price Chart INCR Stock Price Chart Receive SYRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Syros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SYRS) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.